Literature DB >> 17486610

Effects of gonadotrophins, growth hormone, and activin A on enzymatically isolated follicle growth, oocyte chromatin organization, and steroid secretion.

Safiriyu Idowu Ola1, Jun-Shu Ai, Jing-He Liu, Qiang Wang, Zhen-Bo Wang, Da-Yuan Chen, Qing-Yuan Sun.   

Abstract

So far, standard follicle culture systems can produce blastocyst from less than 40% of the in vitro matured oocytes compared to over 70% in the in vivo counterpart. Because the capacity for embryonic development is strictly associated with the terminal stage of oocyte growth, the nuclear maturity status of the in vitro grown oocyte was the subject of this study. Mouse early preantral follicles (100-130 microm) and early antral follicles (170-200 microm) isolated enzymatically were cultured for 12 and 4 days, respectively, in a collagen-free dish. The serum-based media were supplemented with either 100 mIU/ml FSH (FSH only); 100 mIU/ml FSH + 10 mIU/ml LH (FSH-LH); 100 mIU/ml FSH + 1 mIU/ml GH (FSH-GH) or 100 mIU/ml FSH + 100 ng/ml activin A (FSH-AA). Follicle survival was highest in follicle stimulating hormone (FSH)-AA group in both cultured preantral (91.8%) and antral follicles (82.7%). Survival rates in the other groups ranged between 48% (FSH only, preantral follicle culture) and 78.7% (FSH only, antral follicle culture). Estradiol and progesterone were undetectable in medium lacking gonadotrophins while AA supplementation in synergy with FSH caused increased estradiol secretion and a simultaneously lowered progesterone secretion. Chromatin configuration of oocytes from surviving follicles at the end of culture revealed that there were twice more developmentally incompetent non-surrounded nucleolus (NSN) oocytes (>65%) than the competent surrounded nucleolus (SN) oocytes (<34%). We conclude that the present standard follicle culture system does not produce optimum proportion of developmentally competent oocytes. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17486610     DOI: 10.1002/mrd.20762

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

1.  Activin promotes follicular integrity and oogenesis in cultured pre-antral bovine follicles.

Authors:  M McLaughlin; J J Bromfield; D F Albertini; E E Telfer
Journal:  Mol Hum Reprod       Date:  2010-03-04       Impact factor: 4.025

2.  Effects of sodium alginate capsules as 3D scaffolds on hormones and genes expression in preantral follicles of mice compared to 2D medium: An experimental study.

Authors:  Cyrus Jalili; Fuzieh Khani Hemmatabadi; Kamran Mansouri; Mehrdad Bakhtiyari
Journal:  Int J Reprod Biomed       Date:  2020-07-22

3.  A novel two-step strategy for in vitro culture of early-stage ovarian follicles in the mouse.

Authors:  Shi Ying Jin; Lei Lei; Ariella Shikanov; Lonnie D Shea; Teresa K Woodruff
Journal:  Fertil Steril       Date:  2009-12-11       Impact factor: 7.329

4.  The association of two single nucleotide polymorphisms (SNPs) in growth hormone (GH) gene with litter size and superovulation response in goat-breeds.

Authors:  Chunyan Zhang; Yun Liu; Kunkun Huang; Wenbing Zeng; Deqing Xu; Qunying Wen; Liguo Yang
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

5.  Ultrastructure of isolated mouse ovarian follicles cultured in vitro.

Authors:  Stefania A Nottola; Sandra Cecconi; Serena Bianchi; Cecilia Motta; Gianna Rossi; Maria A Continenza; Guido Macchiarelli
Journal:  Reprod Biol Endocrinol       Date:  2011-01-13       Impact factor: 5.211

6.  Genetic and cellular aspects of the establishment of histocompatible stem cells: information gained from an animal model.

Authors:  Jeong Mook Lim; Seung Pyo Gong
Journal:  BMC Proc       Date:  2011-06-03

7.  Activated ovarian endothelial cells promote early follicular development and survival.

Authors:  Alon Kedem; Anate Aelion-Brauer; Peipei Guo; Duancheng Wen; Bi-Sen Ding; Raphael Lis; Du Cheng; Vladislav M Sandler; Shahin Rafii; Zev Rosenwaks
Journal:  J Ovarian Res       Date:  2017-09-19       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.